Gemina Laboratories Ltd.: Gemina Labs Completes Influenza A/

VANCOUVER, BC / ACCESSWIRE / January 6, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the completion of its influenza A/B rapid test prototype.

Related Keywords

Canada , Vancouver , British Columbia , Canadian , John Davies , Brian Firth , Bristol Capital Ltd , Neither The Canadian Securities Exchange , Company Or Gemina , Gemina Laboratories Ltd View , Canadian Securities Exchange , Regulation Services Provider , Gemina Laboratories Ltd , Gemina Laboratories , Gemina Benchmark Test , Lateral Flow Assay , Bristol Capital , Gemina , Laboratories , Labs , Ompletes , Influenza , Iagnostic , Pest , Prototype ,